Average Co-Inventor Count = 2.14
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Translational Drug Development, LLC (13 from 13 patents)
2. The Translational Genomics Research Institute (9 from 119 patents)
3. Van Andel Research Institute (3 from 26 patents)
4. Silamed, Inc. (1 from 1 patent)
5. Translation Drug Development, LLC (1 from 1 patent)
6. Tong Wang (0 patent)
7. Stephen Gately (0 patent)
24 patents:
1. 12076401 - Benzamide and active compound compositions and methods of use
2. 11780816 - Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase
3. 11555039 - Amide compounds as kinase inhibitors, compositions and methods of treatment
4. 11420947 - (S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereof
5. 11236052 - Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase
6. 10881733 - Benzamide and active compound compositions and methods of use
7. 10807966 - Heterocyclic compounds as kinase inhibitors
8. 10780080 - Benzamide and active compound compositions and methods of use
9. 10738007 - Amide compounds as kinase inhibitors, compositions and methods of treatment
10. 10633393 - Heterocyclic compounds as kinase inhibitors
11. 10590088 - 4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof
12. 10584119 - Pyrazole compounds and methods of use thereof
13. 10544100 - Autophagy inhibitors
14. 10392402 - Heterocyclic compounds as kinase inhibitors
15. 10131654 - Pyrazole compounds and methods of use thereof